Showing results (1301-1310 of 3,791) with videos related to
Sort By:
Pageof 380
Oncoimmunology|July 30, 2013
Endogenous tumor-reactive CD8+ T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growthXin Liu, Rachel M Gibbons, Susan M Harrington, et al.Oncoimmunology|July 30, 2013
The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppressionDaniela Basso, Paola Fogar, Mario PlebaniOncoimmunology|July 30, 2013
Strategies for purging CD96+ stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemiaMatthias Staudinger, Andreas Humpe, Martin GramatzkiOncoimmunology|July 30, 2013
Toward understanding the genetics of regulatory T cells in ovarian cancerMelissa S Derycke, Bridget Charbonneau, Claudia C Preston, et al.Oncoimmunology|June 5, 2013
Toll-like receptor 5 and the emerging role of bacteria in carcinogenesisJoonas H Kauppila, Antti E Mattila, Tuomo J Karttunen, et al.Oncoimmunology|June 5, 2013
Lessons learned from a highly-active CD22-specific chimeric antigen receptorAdrienne H Long, Waleed M Haso, Rimas J OrentasOncoimmunology|June 5, 2013
A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous systemBryan D Choi, Ira Pastan, Darell D Bigner, et al.Oncoimmunology|June 27, 2013
DEC-205 is a cell surface receptor for CpG oligonucleotidesIrina Caminschi, Simone Meuter, William R HeathOncoimmunology|June 27, 2013
Bacteria evade immune recognition via TLR13 and binding of their 23S rRNA by MLS antibiotics by the same mechanismsHubertus Hochrein, Carsten J KirschningOncoimmunology|June 27, 2013
HEPA and PARSE: Systematic discovery of clinically relevant tumor-specific antigensQing-Wen Xu, Yu Zhang, Xiao-Song WangPageof 380